Skip to main content
. 2022 May 5;11(9):2584. doi: 10.3390/jcm11092584

Table 1.

Depicts organ at risk (OAR) dose constraints as used in the stereotactic MR-guided adaptive radiation therapy (SMART) trial.

Organ at Risk Dose Constraint
Stomach, duodenum, small bowel V35 < 0.5 mL
V40 < 0.03 mL
Large bowel V38 < 0.5 mL
V43 < 0.03 mL
Kidneys Dmean < 10 Gy
Liver Dmean < 15 Gy
Spinal cord V25 < 0.03 mL